TP53 and urinary bladder cancer: Moreover, TP53 was involved in gene mutation classifier constructed by Luo et al. to guide the ICIs treatment for bladder cancer patients from Memorial Sloan Kettering Cancer Center, TCGA and other cohorts (Pan et al., 2021).